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Figure S1. Related to Figure 1 
S1A) ChIP-seq tracks displaying occupancy of β-catenin, STAT3, SMAD3 and MED1 at 
the super-enhancer of the miR290 gene. Reads densities are displayed in reads per 
million per bin (rpm/bin) and the super-enhancer is indicated with a red bar. 
S1B.) Immunofluorescence for β-catenin, STAT3, SMAD3 and MED1 with concurrent 
RNA-FISH for miR290 nascent RNA demonstrating the presence of condensed nuclear 
foci of the signaling factors at the miR290 super-enhancer in mES cells. Cells were 
grown for 24 hours in the presence of CHIR99021, LIF or Activin A prior to fixation. 
Hoechst staining was used to determine the nuclear periphery, highlighted with a dotted 
line. 100x objective was used for imaging on a spinning disk confocal microscope. 
Average RNA-FISH signal and average IF signal centered on the RNA-FISH focus for 
each signaling factor from at least 10 images is shown. Average signaling factor IF 
signal at randomly selected nuclear positions is displayed in the right most panel. Scale 
bars indicate 5 µm. 
S1C) Immunofluorescence for β-catenin with concurrent DNA-FISH for Nanog 
demonstrating the absence of nuclear foci of the signaling factors at the Nanog super-
enhancer in C2C12 cells. Cells were grown for 24 hours in the presence of CHIR99021 
prior to fixation. Hoechst staining was used to determine the nuclear periphery, 
highlighted with a dotted line.100x objective was used for imaging on a spinning disk 
confocal microscope. Average DNA-FISH signal and average IF signal centered on the 
DNA-FISH focus for each signaling factor from at least 10 images is shown. Average 
signaling factor IF signal at randomly selected nuclear positions is displayed in the right 
most panel. Scale bar indicates 5 µm. 
S1D) Western blot showing levels of endogenously tagged mEGFP- β-catenin in 
comparison to endogenous β-catenin in HCT116 cells, and mEGFP-Hp1α in engineered 
HCT116 cells compared to Hp1α in wild type cells. 
S1E) Live-cell imaging of HCT116 with endogenously-tagged mEGFP-β-catenin before 
and after treatment with 10% 1,6-hexanediol or vehicle for 30 seconds. Hexanediol 
treatment led to a sharp reduction in bright -β-catenin foci in vivo. Images were obtained 
using a Zeiss LSM880 confocal microscope with and Airyscan detector at 63x 
magnification. Scalebar indicates 2um. 
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Figure S2. Related to Figure 2 
Domain structures of β-catenin, STAT3 and SMAD3 the signaling factors used in this 
manuscript. DBD: DNA binding domain, PID: protein interaction domain, CC: coiled coil 
domain, DD: dimerization domain, SH2: Src homology domain 2 . The predicted 
intrinsically disordered regions (IDR) marked in red. PONDR VL3 score per amino acid 
was used to predict disorder and is plotted below. Barcode plots indicate the location of 
different amino acids below. Red boxes indicate the top 3 over-represented amino acids 
in the predicted IDRs of the protein. Lowest panel shows the net charge per residue 
(NCPR) for the indicated protein. 
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Figure S3. Related to Figure 3 
S3A) β-catenin forms droplets with MED1-IDR at nanomolar concentrations of both 
factors. Droplet assays were formed in 10% PEG-8000 and 125mM NaCl and imaged 
using a spinning disk confocal miscroscope and 150x objective. Partition ratio was 
calculated for at least 10 images per condition. 
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Figure S4. Related to Figure 4 
S4A) Partition ratio was calculated by dividing the average fluorescence signal inside the 
droplets by the average fluorescence signal outside the droplets for at least 10 acquired 
images for the condition in which 1.25uM concentration of all factors were used for this 
assay. 
S4B) Representative images of in vitro droplet assays of wild type full length β-catenin 
and mutant full length β-catenin with purified Mediator showing the ability of β-catenin to 
interact and partition into Mediator droplets compared to that of the mutant β-catenin. 
Reactions were performed in the presence of 10% PEG-8000 and 300 nM β-catenin and 
imaged using a spinning disk confocal microscope with a 150x objective. Partition ratio 
was calculated for 10 acquired images in each condition. Scale bars indicate 2 µm. 
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Figure S5. Related to Figure 5 
S5A) Western blot showing expression levels of wild type and mutant β-catenin that 
were integrated in mES cells under a doxycycline inducible promoter compared to those 
of endogenous β-catenin in wild type mES cells. Cell were induced with 1µg/ml 
doxycycline for 24 hours and an inhibitor of the WNT pathway to replace endogenous 
nuclear β-catenin with Td-Tomato- β-catenin or Td-Tomato-aromatic-mutant- β-catenin. 
S5B) ChIP-qPCR for two typical enhancer-driven genes showing that β-catenin and its 
mutant form are not targeted to non-WNT responsive genes. Ns indicates a t-test with a 
p-value of > 0.05.  
S5C) Representative images of Td-Tomato- β-catenin or Td-Tomato-aromatic-mutant- β-
catenin integrated into mES cells imaged using the Zeiss LSM 880 confocal microscope 
with Airyscan detector with a 63x objective. 
S5D) Luciferase assay for a WNT unresponsive reporter showing no activation in two 
overexpressed versions of β-catenin. Quantification was performed for three biological 
replicates. 
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Figure S6. Related to Figure 6 
S6A) IF of LEF1, TCF1, TCF3, and TCF7L2 in Lac-U2OS cells transfected with a Lac 
binding domain-CFP-MED1-IDR construct showing no accumulation of TCF/LEF family 
members in the Lac spot. Images were obtained using a 100x objective on a spinning 
disk confocal microscope. Scale bars indicate 5µm. 
S6B) IF of HP1α in U2OS2-6-3 cells transfected with a Lac binding domain-CFP-MED1-
IDR construct. Images were obtained using a 100x objective on a spinning disk confocal 
microscope. Scale bars indicate 5µm. 
S6C) Co-immunoprecipitation of wild type and mutant forms of β-catenin show both 
factors can interact with TCF7L2. Top: Diagram of experimental setup where HEK293T 
cells were co-transfected with flag-tagged-wild type or flag-tagged-mutant β -catenin and 
ha-tagged-TCF7L2 and either the flag-tagged factor or ha-tagged factor 
immunoprecipitated and blotted for the reciprocal tag.  Bottom: Western blot of 
immunoprecipitated material.  
S6D) ChIP-qPCR for two typical enhancer that are not normally bound by β-catenin 
shows no enrichment of β -catenin, chimera or mutant chimera at this gene. 
S6E) Western blot showing the levels of wild type β-catenin, chimera or chimera mutant 
protein in HEK293T cells compared to endogenous β-catenin. β -actin was used as a 
loading control. 
S6F) Luciferase assay for a WNT unresponsive reporter showing no activation of 
luciferase expression in the presence of wt, chimera and chimera mutant forms of β-
catenin. Untransfected control and WT FL- β-catenin came from the same experiment 
and are the same as in Figure S5, but displayed in two different graphs. 
S6G) Expression of the Lac array is lower in the presence of mutant β-catenin than in 
wild-type β-catenin. RT-qPCR for CFP for engineered U2OS cells untransfected 
(control), or transfected with wild-type or mutant forms of β-catenin and MED1-IDR. Star 
represents a p-value of <0.05 in a t-test. 
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Figure S7. Related to Figure 7 
S7A) Western blot of mES cells expresssing mEGFP-tagged- β-catenin, mEGFP-
tagged-armadillo-repeats (armadillo) and mEGFP-tagged-IDRs (chimera). The 
endogenous β-catenin locus was tagged and the armadillo-repeats and IDRs integrated 
into mES cells using a transposable system.  
S7B) ChIP-seq tracks of two typical-enhancer-associated genes show no association of 
β-catenin, armadillo or chimera with these sites. 
  
Table S1. Oligonucleotides used in this study
ChIP-qPCR
ChIP-negative-FWD ACACAACATCTGCCCAAACA
ChIP-negative-REV TGAGATCCTGGTGTGACCAA
Klf4-1-FWD AGGGTGATGAATGGATCAGG
Klf4-1-REV CTCTCCCCACGAATTAACGA
Myc -1-FWD CCAGTGAACAAAAGTGCAA
Myc -1-REV TCCAGGCACATCTCAGTTTG
Sp5 -1-FWD GGAGCTCGCTTTAGTCCTCA
Sp5 -1-REV CCCCCACTTGCAATTAAAGA
ChIP-negative-hu-FWD CTCCCTTCCATCTTCCCTTC
ChIP-negative-hu-REV TGCTTTCTTGGGGCATTAAC
SOX9-FWD CTGTTGGGAATTCAGCCAAT
SOX9-REV AATGAAGGGAGTGCAGGATG
SMAD7-FWD AAATCCATCGGGTATCTGGA
SMAD7-REV AGGCGGCCTCTTTTGTTTAT
KLF9-FWD GCTCTGAAACCTGGCTCATC
KLF9-REV ATTCTCTTGTCGGGTTGCAG
huTE1_F GAGGGTAGGCTTTGTGGTGA
huTE1_R AGGCTCATCTCACCTCTGGA
huTE2_F GCTGTAGACCGGAGCTGTTC
huTE2_R GGGACATGCTTTTTGATGCT
Actrt2_enhancer_FWD actgctactgctgcccactt
Actrt2_enhancer_REV tcctttgtttgggtcaggtc
Fam168b qPCR Primer F CGGTGGTGATGGAAACTTCT
Fam168b qPCR Primer 2 TCCCAAATGTTGGGGTTAAA
RT-qPCR
human gapdh rt primer f TGCACCACCAACTGCTTAGC
human gapdh rt primer r GGCATGGACTGTGGTCATGAG
CFP rt primer f CGTGACCACCCTGACCTGG
CFP rt primer r TCCTGGACGTAGCCTTCGG
mGapdh-FWD CCATGTAGTTGAGGTCAATGAAGG
mGapdh-REV TGGTGAAGGTCGGTGTGAAC
mKlf4-FWD CTCCCGTCCTTCTCCACGTT
mKlf4-REV TTCCTCACGCCAACGGTTA
Table S1. Related to Figures 5 & 6 and STAR Methods. 
Oligonucleotides used in this study. 
Movie S1 Related to Figure 3. 
Timelapse imaging of preformed MED1-IDR droplets in 10% PEG-8000 to which 10 µM 
dilute β-catenin was added. Time interval 30 seconds. Magnification 150x. 
  
Movie S2 Related to Figure 3. 
Timelapse imaging of preformed MED1-IDR droplets in 10% PEG-8000 to which 10 µM 
dilute mEGFP-STAT3 was added. Time interval 30 seconds. Magnification 150x. 
 
Movie S3 Related to Figure 3. 
Timelapse imaging of preformed MED1-IDR droplets in 10% PEG-8000 to which 10 µM 
dilute mEGFP-SMAD3 was added. Time interval 30 seconds. Magnification 150x. 
 
